DELETION OF BONE MARROW OR NON-BONE MARROW DERIVED RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS ATTENUATES DIABETES-ASSOCIATED ATHEROSCLEROSIS

被引：0
|
作者：
Koulis, C. [1 ]
Kanellakis, P. [1 ]
Pickering, R. J. [1 ]
Tsorotes, D. [1 ]
Thomas, M. C. [1 ]
Cooper, M. E. [1 ]
Jandeleit-Dahm, K. A. [1 ]
Allen, T. J. [1 ]
机构：
[1] Baker IDI Heart & Diabet Res Inst, Melbourne, Vic, Australia
来源：
HYPERTENSION | 2014年 / 63卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E168 / E168
页数：1
相关论文
共 50 条
  • [1] Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis
    Koulis, Christine
    Kanellakis, Peter
    Pickering, Raelene J.
    Tsorotes, Despina
    Murphy, Andrew J.
    Gray, Stephen P.
    Thomas, Merlin C.
    Jandeleit-Dahm, Karin A. M.
    Cooper, Mark E.
    Allen, Terri J.
    CLINICAL SCIENCE, 2014, 127 (7-8) : 485 - 497
  • [2] Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression
    Morris-Rosenfeld, Samuel
    Blessing, Erwin
    Preusch, Michael R.
    Albrecht, Claudia
    Bierhaus, Angelika
    Andrassy, Martin
    Nawroth, Peter P.
    Rosenfeld, Michael E.
    Katus, Hugo A.
    Bea, Florian
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (11) : 1164 - 1171
  • [3] CD44 expressed in bone marrow as well as non-bone marrow derived cells promotes atherosclerosis
    Zhao, L
    Hall, J
    Pure, E
    CIRCULATION, 2005, 112 (17) : U218 - U218
  • [4] Deletion of Bone Marrow Derived Receptor for Advanced Glycation End-products (RAGE) Does Not Attenuate Plaque Formation but Inhibits Plaque Progression in a Mouse Model of Advanced Atherosclerosis
    Preusch, Michael R.
    Morris-Rosenfeld, Sam
    Bierhaus, Angelika
    Albrecht, Claudia
    Blessing, Erwin
    Andrassy, Martin
    Katus, Hugo A.
    Bea, Florian
    CIRCULATION, 2009, 120 (18) : S1137 - S1138
  • [5] Ligands Of The Receptor For Advanced Glycation End Products Induce Trained Immunity In Mouse Bone Marrow-Derived Macrophages
    Kumar, Vikas
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
  • [6] Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
    Soro-Paavonen, Aino
    Watson, Anna M. D.
    Li, Jiaze
    Paavonen, Karri
    Koitka, Audrey
    Calkin, Anna C.
    Barit, David
    Coughlan, Melinda T.
    Drew, Brian G.
    Lancaster, Graeme I.
    Thomas, Merlin
    Forbes, Josephine M.
    Nawroth, Peter P.
    Bierhaus, Angelika
    Cooper, Mark E.
    Jandeleit-Dahm, Karin A.
    DIABETES, 2008, 57 (09) : 2461 - 2469
  • [7] Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow
    Benfang Wang
    Jianjiang Yu
    Ting Wang
    Ying Shen
    Dandan Lin
    Xin Xu
    Yiqiang Wang
    Acta Diabetologica, 2018, 55 : 419 - 427
  • [8] Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow
    Wang, Benfang
    Yu, Jianjiang
    Wang, Ting
    Shen, Ying
    Lin, Dandan
    Xu, Xin
    Wang, Yiqiang
    ACTA DIABETOLOGICA, 2018, 55 (05) : 419 - 427
  • [9] Advanced Glycation End Products, Diabetes, and Bone Strength
    Yamamoto, Masahiro
    Sugimoto, Toshitsugu
    CURRENT OSTEOPOROSIS REPORTS, 2016, 14 (06): : 320 - 326
  • [10] IA ANTIGENS IN MOUSE KIDNEY ARE EXPRESSED BOTH ON BONE-MARROW DERIVED CELLS AND ON NON-BONE MARROW DERIVED CELLS
    HALLORAN, PF
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 686 - 686
12345